237 related articles for article (PubMed ID: 24212803)
1. Predictive factors of the response of rectal cancer to neoadjuvant radiochemotherapy.
Spolverato G; Pucciarelli S; Bertorelle R; De Rossi A; Nitti D
Cancers (Basel); 2011 Apr; 3(2):2176-94. PubMed ID: 24212803
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for response to neoadjuvant chemoradiation for rectal cancer.
Kuremsky JG; Tepper JE; McLeod HL
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):673-88. PubMed ID: 19480968
[TBL] [Abstract][Full Text] [Related]
3. Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy.
Rau B; Sturm I; Lage H; Berger S; Schneider U; Hauptmann S; Wust P; Riess H; Schlag PM; Dörken B; Daniel PT
J Clin Oncol; 2003 Sep; 21(18):3391-401. PubMed ID: 12885834
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers for cetuximab-based neoadjuvant radiochemotherapy in locally advanced rectal cancer.
Grimminger PP; Danenberg P; Dellas K; Arnold D; Rödel C; Machiels JP; Haustermans K; Debucquoy A; Velenik V; Sempoux C; Bracko M; Hölscher AH; Semrau R; Yang D; Danenberg K; Lenz HJ; Vallböhmer D
Clin Cancer Res; 2011 May; 17(10):3469-77. PubMed ID: 21558395
[TBL] [Abstract][Full Text] [Related]
5. High-Risk Clinicopathological and Genetic Features and Outcomes in Patients Receiving Neoadjuvant Radiochemotherapy for Locally Advanced Rectal Cancer.
Del Carmen S; Corchete LA; González Velasco C; Sanz J; Alcazar JA; García J; Rodríguez AI; Vidal Tocino R; Rodriguez A; Pérez-Romasanta LA; Sayagués JM; Abad M
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34202891
[TBL] [Abstract][Full Text] [Related]
6. [Predictive value of serum carcinoembryonic antigen level in efficacy and prognosis for patients with rectal cancer following preoperative radiochemotherapy].
Zhang D; Zhan T; Li M; Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):519-523. PubMed ID: 28534328
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of Ki67 and p53 in locally advanced rectal cancer: correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapy.
Jakob C; Liersch T; Meyer W; Becker H; Baretton GB; Aust DE
World J Gastroenterol; 2008 Feb; 14(7):1060-6. PubMed ID: 18286688
[TBL] [Abstract][Full Text] [Related]
9. MTHFR C677T Polymorphism is Associated with Tumor Response to Preoperative Chemoradiotherapy: A Result Based on Previous Reports.
Zhao Y; Li X; Kong X
Med Sci Monit; 2015 Oct; 21():3068-76. PubMed ID: 26456456
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis, proliferation, bax, bcl-2 and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer.
Tannapfel A; Nüsslein S; Fietkau R; Katalinic A; Köckerling F; Wittekind C
Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):585-91. PubMed ID: 9635706
[TBL] [Abstract][Full Text] [Related]
11. Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy.
Smith FM; Reynolds JV; Miller N; Stephens RB; Kennedy MJ
Eur J Surg Oncol; 2006 Feb; 32(1):55-64. PubMed ID: 16324817
[TBL] [Abstract][Full Text] [Related]
12. Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy.
Negri FV; Campanini N; Camisa R; Pucci F; Bui S; Ceccon G; Martinelli R; Fumagalli M; Losardo PL; Crafa P; Bordi C; Cascinu S; Ardizzoni A
Br J Cancer; 2008 Jan; 98(1):143-7. PubMed ID: 18087284
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer.
Cheong C; Shin JS; Suh KW
World J Gastroenterol; 2020 Nov; 26(44):7022-7035. PubMed ID: 33311947
[TBL] [Abstract][Full Text] [Related]
14. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.
Saw RP; Morgan M; Koorey D; Painter D; Findlay M; Stevens G; Clarke S; Chapuis P; Solomon MJ
Dis Colon Rectum; 2003 Feb; 46(2):192-202. PubMed ID: 12576893
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment expression of 13 molecular markers as a predictor of tumor responses after neoadjuvant chemoradiation in rectal cancer.
Huh JW; Lee JH; Kim HR
Ann Surg; 2014 Mar; 259(3):508-15. PubMed ID: 23787217
[TBL] [Abstract][Full Text] [Related]
16. Small heterodimer partner as a predictor of neoadjuvant radiochemotherapy response and survival in patients with rectal cancer: A preliminary study.
Kim S; Joo M; Yeo MK; Cho MJ; Kim JS; Jo EK; Kim JM
Oncol Lett; 2021 Oct; 22(4):708. PubMed ID: 34457063
[TBL] [Abstract][Full Text] [Related]
17. Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal Cancer.
Dayde D; Gunther J; Hirayama Y; Weksberg DC; Boutin A; Parhy G; Aguilar-Bonavides C; Wang H; Katayama H; Abe Y; Do KA; Hara K; Kinoshita T; Komori K; Shimizu Y; Tajika M; Niwa Y; Wang YA; DePinho R; Hanash S; Krishnan S; Taguchi A
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298853
[TBL] [Abstract][Full Text] [Related]
18. Thymidylate synthase as a prognostic biomarker for locally advanced rectal cancer after multimodal treatment.
Conradi LC; Bleckmann A; Schirmer M; Sprenger T; Jo P; Homayounfar K; Wolff HA; Rothe H; Middel P; Becker H; Ghadimi MB; Beissbarth T; Liersch T
Ann Surg Oncol; 2011 Sep; 18(9):2442-52. PubMed ID: 21347782
[TBL] [Abstract][Full Text] [Related]
19. Promises and Challenges of Predictive Blood Biomarkers for Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.
Machado Carvalho JV; Dutoit V; Corrò C; Koessler T
Cells; 2023 Jan; 12(3):. PubMed ID: 36766755
[TBL] [Abstract][Full Text] [Related]
20. The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma.
Edden Y; Wexner SD; Berho M
Colorectal Dis; 2012 May; 14(5):555-61. PubMed ID: 21689364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
